Rabbit Recombinant Monoclonal ErbB2 / HER2 antibody. Suitable for Flow Cyt, ICC, IHC-P, IP, WB and reacts with Human, Mouse samples. Immunogen corresponding to Synthetic Peptide within Human ERBB2 aa 1200 to C-terminus.
pH: 7.8 - 8.6
Preservative: 0.09% Sodium azide
Constituents: 98% Borate buffered saline
Flow Cyt | ICC | IHC-P | IP | WB | |
---|---|---|---|---|---|
Human | Tested | Tested | Tested | Tested | Tested |
Mouse | Tested | Expected | Expected | Expected | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse | Dilution info - | Notes - |
The protein expressed by the ERBB2 gene is a protein tyrosine kinase involved in several cell surface receptor complexes, requiring a coreceptor for ligand binding. It is an essential component of a neuregulin-receptor complex, although neuregulins do not bind to it directly. GP30 is a potential ligand for this receptor. ERBB2 regulates the outgrowth and stabilization of peripheral microtubules (MTs) via the MEMO1-RHOA-DIAPH1 signaling pathway, which, upon activation, phosphorylates and inhibits GSK3B at the cell membrane. This prevents APC and CLASP2 phosphorylation, allowing their association with the cell membrane, facilitating MACF1 localization necessary for microtubule capture and stabilization. In the nucleus, ERBB2 is involved in transcriptional regulation, associating with the 5'-TCAAATTC-3' sequence in the PTGS2/COX-2 promoter to activate transcription. It is implicated in the transcriptional activation of CDKN1A, involving STAT3 and SRC, and participates in the transcription of rRNA genes by RNA Pol I, thereby enhancing protein synthesis and cell growth. This supplementary information is collated from multiple sources and compiled automatically.
CD340, HER2, MLN19, NEU, NGL, ERBB2, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, MLN 19
Rabbit Recombinant Monoclonal ErbB2 / HER2 antibody. Suitable for Flow Cyt, ICC, IHC-P, IP, WB and reacts with Human, Mouse samples. Immunogen corresponding to Synthetic Peptide within Human ERBB2 aa 1200 to C-terminus.
pH: 7.8 - 8.6
Preservative: 0.09% Sodium azide
Constituents: 98% Borate buffered saline
The ErbB2 also known as HER2 or HER2 protein is a transmembrane receptor protein with a molecular weight of about 185 kDa. It serves as part of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. The ErbB2 protein is expressed mainly in epithelial tissues including those of the breast and the gastrointestinal tract. It lacks a known ligand-binding domain which sets it apart from other members of its family. Due to its structure ErbB2 dimerizes with other members of the EGFR family to exert its effects in cellular signaling.
The role of ErbB2 extends beyond a singular function. It becomes an active component when forming heterodimers with other EGFR family members such as ErbB3 to initiate various downstream signaling cascades. The dimerization activates intracellular pathways leading to cell proliferation survival differentiation and migration. Within cells ErbB2 influences processes critical for normal development and tissue homeostasis contributing significantly to signal transduction networks.
ErbB2 plays a pivotal role in pathways such as the PI3K/Akt and MAPK/ERK pathways. These pathways are important in mediating cellular responses to growth signals. The PI3K/Akt pathway activated by HER2 signaling regulates cell growth and survival while the MAPK/ERK pathway contributes to cell differentiation and proliferation. ErbB2's interaction with proteins like ErbB3 is fundamental in these pathways increasing the amplitude and diversity of downstream signals.
ErbB2 is significantly associated with breast cancer and gastric cancer. The overexpression or gene amplification of HER2 is observed in approximately 20% of breast cancer cases correlating with aggressive tumor growth and poor prognosis. ErbB2-related signaling contributes to oncogenic processes by promoting excessive cell proliferation. Targeting ErbB2 in these cancers is common using therapies such as monoclonal antibodies like trastuzumab. In the context of gastric cancer the role of ErbB2 mirrors its function in breast cancer and targeting HER2 holds therapeutic potential.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Detection of human HER2/ErbB2 (shaded) in FaDu cells by flow cytometry. Antibody: Rabbit anti-HER2/ErbB2 recombinant monoclonal antibody [BLR241L] (A700-241) or isotype control (unshaded). Secondary: DyLight® 650-conjugated goat anti-rabbit IgG.
Detection of mouse HER2/ErbB2 (shaded) in NIH3T3 cells by flow cytometry. Antibody: Rabbit anti-HER2/ErbB2 recombinant monoclonal antibody [BLR241L] (A700-241CF) or isotype control (unshaded). Secondary: DyLight® 650-conjugated goat anti-rabbit IgG.
Samples: Whole cell lysate (10 µg) from LNCaP, HeLa, HT-29, HEK293T, and MCF-7 cells prepared using NETN lysis buffer. Antibody: Rabbit anti-HER2/ErbB2 recombinant monoclonal antibody [BLR241L] (A700-241) used at 1:1000. Secondary: HRP-conjugated goat anti-rabbit IgG. Detection: Chemiluminescence with an exposure time of 10 seconds. Lower Panel: Rabbit anti-Actin recombinant monoclonal antibody [BLR057F].
All lanes: Western blot - Anti-HER2/ErbB2 antibody [BLR241L] - BSA free (ab314070) at 1/1000 dilution
Lane 1: LNCaP Whole cell lysate at 10 µg
Lane 2: HeLa Whole cell lysate at 10 µg
Lane 3: HT-29 Whole cell lysate at 10 µg
Lane 4: HEK293T Whole cell lysate at 10 µg
Lane 5: MCF-7 Whole cell lysate at 10 µg
All lanes: HRP-conjugated goat anti-rabbit IgG
Samples: Whole cell lysate (10 µg) from NIH 3T3, CT26, and TCMK-1 cells prepared using NETN lysis buffer. Antibody: Rabbit anti-HER2/ErbB2 recombinant monoclonal antibody [BLR241L] (A700-241) used at 1:1000. Secondary: HRP-conjugated goat anti-rabbit IgG. Detection: Chemiluminescence with an exposure time of 30 seconds. Lower Panel: Rabbit anti-Actin recombinant monoclonal antibody [BLR057F].
All lanes: Western blot - Anti-HER2/ErbB2 antibody [BLR241L] - BSA free (ab314070) at 1/1000 dilution
Lane 1: NIH 3T3 Whole cell lysate at 10 µg
Lane 2: CT26 Whole cell lysate at 10 µg
Lane 3: TCMK-1 Whole cell lysate at 10 µg
All lanes: HRP-conjugated goat anti-rabbit IgG
Sample: FFPE section of human breast carcinoma. Antibody: Rabbit anti-HER2/ErbB2 recombinant monoclonal antibody [BLR241L) (A700-241CF). Secondary: HRP-conjugated goat anti-rabbit IgG.
Sample: FFPE section of LNCaP cells. Antibody: Rabbit anti-HER2/ErbB2 recombinant monoclonal antibody [BLR241L) (A700-241CF). Secondary: HRP-conjugated goat anti-rabbit IgG .
Samples: Whole cell lysate (1.0 mg per IP reaction; 20% of IP loaded) from HeLa cells prepared using NETN lysis buffer. Antibodies: Rabbit anti-HER2/ErbB2 recombinant monoclonal antibody [BLR241L] (A700-241-1) used for IP at 20 µl/mg lysate. HER2/ErbB2 was also immunoprecipitated by a second antibody against a different epitope of HER2/ErbB2 (A301-621A). For blotting immunoprecipitated HER2/ErbB2, A700-241 was used at 1:1000. Detection: Chemiluminescence with an exposure time of 1 second.
All lanes: Immunoprecipitation - Anti-HER2/ErbB2 antibody [BLR241L] - BSA free (ab314070)
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com